CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- SC TO-I Deal Tender Offer Statement by Issuer
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 4 Open-market buy Director bought 20,000 shares at $1.25 ($25,000)
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Open-market buy CEO and President bought 10,000 shares at $1.30 ($13,000)
- 4 Open-market buy Director bought 25,000 shares at $1.30 ($32,500)
- 4 Open-market sale Director sold 80,000 shares at $1.30 ($104,000)
- 4 Open-market buy Director bought 25,000 shares at $1.30 ($32,500)
- 4 Open-market buy CFO bought 10,000 shares at $1.30 ($13,000)
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $1.30 ($13,000)
- 10-K Report Annual Report
- 4 Open-market buy Chief Scientific Officer bought 5,000 shares at $1.56 ($7,808)
- 4 Open-market buy CEO and PRESIDENT bought 5,000 shares at $1.00 ($5,000)
- 4 Open-market buy CEO and PRESIDENT bought 5,000 shares at $0.80 ($4,000)
- 4 Open-market buy Director bought 9,000 shares at $0.83 ($7,504)
- 4 Open-market buy Director bought 9,000 shares at $0.88 ($7,920)
Page 42 of 47 · 929 filings